Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

You’ve viewed 1 of 5 articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.

A 5-fraction, 1-week schedule of adjuvant breast radiotherapy is as safe and effective as a standard 3-week schedule for patients with invasive breast cancer who have undergone breast surgery.

A scientific statement has been published by the AHA regarding palliative care and advanced cardiovascular disease in adults.

Topline data were announced from a phase 3 trial evaluating CTx-1301 for the treatment of pediatric patients aged 6 to 17 years with ADHD.

Transcutaneous auricular vagus nerve stimulation (tVNS) may be a safe pain-relieving treatment for people with knee osteoarthritis (OA).

Certain groups of physical multimorbidity may be associated with a higher risk of subsequent depression, according to a study.

The FDA has accepted for review the resubmitted NDA for ND0612 for the treatment of motor fluctuations in patients with Parkinson disease.

Dr Joshua D Safer and Dr C Streed Jr discuss the importance of cardiovascular care among transgender and gender-diverse patients.

Sedentary behavior among US adults fell between 2013 and 2020 but plateaued after that, according to a research letter published online.

Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in confirmatory trials, with a lower dose of medication.

In primary care, manual-based psychotherapy and family and friend involvement were the most effective for reducing depressive symptoms.